Physician profile
Scott D Brook
NPI 1245424365
$3,934.18
in general payments reported to CMS, 2019-2025
46 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $104 · 2021: $98.57 · 2022: $231 · 2023: $368 · 2024: $1,048 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,722 · Education: $16.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,722.02 |
| Education | $16.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $515.44 | 2019-2025 | Reblozyl, Opdivo |
| Astrazeneca Pharmaceuticals LP | $376.23 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Eisai INC. | $236.73 | 2023-2025 | |
| Janssen Biotech, INC. | $209.61 | 2023-2025 | Darzalex, Talvey, Carvykti |
| Celgene Corporation | $186.18 | 2021-2025 | Pomalyst, Opdualag, Pomalyst |
| Amgen INC. | $153.61 | 2019-2023 | Nplate, Xgeva |
| Karyopharm Therapeutics INC. | $150.76 | 2023-2025 | Xpovio |
| Abbvie INC. | $145.87 | 2024-2025 | |
| Genzyme Corporation | $132.71 | 2019-2024 | |
| Array Biopharma INC | $131.83 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Pfizer INC. | $110.88 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $106.25 | 2024-2025 | |
| Sobi, INC | $98.17 | 2022-2024 | |
| Menarini Silicon Biosystems, INC. | $96.08 | 2023 | Cellsearch |
| Ge Healthcare | $93.69 | 2025 |
Show all 44 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.